| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 | £ 0.00 |
| Gross Profit | £ -588.75K | £ -639.28K | £ -645.68K | £ -2.60M | £ -283.65K |
| Operating Income | £ -4.66M | £ -5.73M | £ -5.56M | £ 4.00M | £ -2.70M |
| EBITDA | £ -4.07M | £ -4.71M | £ -5.73M | £ -3.42M | £ -2.39M |
| Net Income | £ -9.76M | £ -5.62M | £ -6.69M | £ -3.98M | £ -5.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 1.59M | £ 159.26K | £ 1.25M | £ 2.53M | £ 6.84M |
| Total Assets | £ 4.18M | £ 4.21M | £ 6.11M | £ 7.09M | £ 8.52M |
| Total Debt | £ 2.00M | £ 2.62M | £ 2.95M | £ 3.42M | £ 10.15K |
| Net Debt | £ 417.82K | £ 2.46M | £ 1.70M | £ 890.08K | £ -6.83M |
| Total Liabilities | £ 3.03M | £ 3.36M | £ 3.32M | £ 3.85M | £ 352.84K |
| Stockholders' Equity | £ 1.20M | £ 897.51K | £ 2.82M | £ 3.28M | £ 8.19M |
| Cash Flow | |||||
| Free Cash Flow | £ -3.45M | £ -4.13M | £ -6.22M | £ -3.34M | £ -3.45M |
| Operating Cash Flow | £ -3.45M | £ -4.12M | £ -6.11M | £ -2.91M | £ -2.63M |
| Investing Cash Flow | £ -6.80K | £ -24.90K | £ -31.94K | £ -420.25K | £ -938.95K |
| Financing Cash Flow | £ 4.89M | £ 3.08M | £ 4.45M | £ -110.14K | £ 8.78M |
HemoGenyx Pharmaceuticals Plc (DE:5HU0)
FRANKFURT:5HU0
